Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | NASDAQ | Biotechnology | $5.82B | $36.71 | 0.12% | $97.52M | 89.52x | 1.54 | United States | ||
| CORT | CORCEPT THERAPEUTICS INC | NASDAQ | Biotechnology | $9.29B | $88.15 | 3.12% | $102.16M | 69.96x | 0.26 | United States | ||
| CRMD | CORMEDIX INC | NASDAQ | Biotechnology | $769.13M | $11.34 | 2.62% | $17.67M | 43.62x | 0.30 | United States | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | NASDAQ | Biotechnology | $2.85B | $38.49 | 2.72% | $19.04M | 641.50x | 0.34 | Bermuda | ||
| HALO | HALOZYME THERAPEUTICS INC | NASDAQ | Biotechnology | $8.07B | $68.98 | -3.78% | $791.84M | 15.40x | 5.17 | United States | ||
| KRYS | KRYSTAL BIOTECH INC | NASDAQ | Biotechnology | $5.31B | $183.36 | 0.92% | $175.01M | 35.88x | 0.09 | United States | ||
| ARGX | ARGENX SE | NASDAQ | Biotechnology | $48.83B | $800.00 | 1.06% | $811.30M | 31.97x | 0.18 | Belgium | ||
| INVA | INNOVIVA INC | NASDAQ | Biotechnology | $1.10B | $17.48 | -0.99% | $125.47M | 28.66x | 0.87 | United States | ||
| VCEL | VERICEL CORP | NASDAQ | Biotechnology | $1.64B | $32.44 | 2.92% | $22.06M | 231.71x | 0.42 | United States | ||
| RPRX | ROYALTY PHARMA PLC | NASDAQ | Biotechnology | $21.04B | $36.07 | -1.15% | $1.29B | 15.61x | 0.93 | United States | ||
| AUPH | AURINIA PHARMACEUTICALS INC | NASDAQ | Biotechnology | $1.49B | $11.35 | 0.80% | $86.50M | 25.80x | 0.50 | Canada | ||
| INCY | INCYTE CORP | NASDAQ | Biotechnology | $16.96B | $86.85 | 0.66% | $1.36B | 19.65x | 0.40 | United States | ||
| EXEL | EXELIXIS INC | NASDAQ | Biotechnology | $10.79B | $40.09 | -3.05% | $831.10M | 18.65x | 0.32 | United States | ||
| GYRE | GYRE THERAPEUTICS INC | NASDAQ | Biotechnology | $713.68M | $7.41 | -1.46% | $9.86M | 185.25x | 0.25 | United States | ||
| ADMA | ADMA BIOLOGICS INC | NASDAQ | Biotechnology | $3.50B | $14.66 | 0.89% | $163.11M | 16.66x | 0.40 | United States | ||
| MDXG | MIMEDX GROUP INC | NASDAQ | Biotechnology | $1.07B | $7.21 | 7.45% | $54.38M | 32.77x | 0.34 | United States | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | NASDAQ | Biotechnology | $1.57B | $27.28 | 1.94% | $265.05M | 8.63x | 0.43 | United States | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | NASDAQ | Biotechnology | $101.20M | $14.41 | -0.48% | $24.86M | 19.74x | -2.05 | United States | ||
| TECH | BIO-TECHNE CORP | NASDAQ | Biotechnology | $9.79B | $62.95 | 1.39% | $216.88M | 133.94x | 0.33 | United States | ||
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | $2.82B | $36.00 | 1.04% | $63.03M | 83.72x | 0.10 | United States | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | $10.64B | $55.43 | -0.25% | $934.37M | 16.11x | 0.24 | United States | ||
| VRTX | VERTEX PHARMACEUTICALS INC | NASDAQ | Biotechnology | $103.40B | $403.30 | -1.36% | $4.59B | 28.56x | 0.40 | United States | ||
| GMAB | GENMAB A | NASDAQ | Biotechnology | $21.53B | $33.56 | 4.48% | $1.82B | 17.03x | 0.22 | Denmark | ||
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | $2.55B | $20.84 | 0.00% | $310.08M | 12.05x | 0.14 | United States | ||
| NVO | NOVO NORDISK A S | NYSE | Biotechnology | $266.25B | $59.63 | 1.52% | $24.46B | 15.31x | 1.87 | Denmark | ||
| MNKD | MANNKIND CORP | NASDAQ | Biotechnology | $1.77B | $5.76 | 4.92% | $79.10M | 52.36x | -8.48 | United States |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.